Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Gayathri Kumar"'
Autor:
Gayathri Kumar, A Suguna, Deodatt M Suryawanshi, A Surekha, Divya Rajaseharan, Kalaipriya Gunasekaran
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 11, Iss 11, Pp 7060-7063 (2022)
Background: Transgender people experience widespread prejudice discrimination, violence and other harms of stigma and trans-phobia (dislike of or prejudice against trans-sexual or transgender people). To study various modes in which transgenders expe
Externí odkaz:
https://doaj.org/article/4c342b0b4ce3420881bc64fc18401b4b
Autor:
Adeline Ruyssen-Witrand, Richard Perry, Clare Watkins, George Braileanu, Gayathri Kumar, Sandeep Kiri, Debby Nott, Soyi Liu-Leage, Susanne Hartz, Christophe Sapin
Publikováno v:
RMD Open, Vol 6, Iss 1 (2020)
Background Biologic disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs are used in patients with psoriatic arthritis (PsA), but few studies directly compare their clinical efficacy. In such situations, network meta-analysis
Externí odkaz:
https://doaj.org/article/79755242a35346c881866cdcd7174c8f
Autor:
Anton Emmanuel, Gayathri Kumar, Peter Christensen, Stuart Mealing, Zenia M Størling, Frederikke Andersen, Steven Kirshblum
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0159394 (2016)
People suffering from neurogenic bowel dysfunction (NBD) and an ineffective bowel regimen often suffer from fecal incontinence (FI) and related symptoms, which have a huge impact on their quality of life. In these situations, transanal irrigation (TA
Externí odkaz:
https://doaj.org/article/af6a8d7e40e14fab872f5660893589a1
Autor:
Tracey L Henry, Gayathri Kumar, Erin Cahill, Stacie R Schmidt, Sara Berney, Jada Bussey-Jones, Amy Webb Girard
Publikováno v:
BMJ Nutrition, Prevention & Health, Vol , Iss
Background Some American households experience food insecurity, where access to adequate food is limited by lack of money and other resources. As such, we implemented a free 6-month Fruit and Vegetable Prescription Program within a large urban safety
Externí odkaz:
https://doaj.org/article/fe570047054147f38a7de332ab39e26f
Autor:
Himani Sharma, Harinath Parathasarathy, Deepa Ponnaiyan, Anupama Tadepalli, Gayathri Kumar, Paras Varma
Publikováno v:
International journal of health sciences. :14407-14418
Background: Human beta defensins (HβDs) expression in healthy tissues may aid in preventing the onset and/or progression of inflammatory disease.Type 2 diabetes mellitus (type 2 DM) and periodontal disease encompass inflammatory changes. HβDs in pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cc78fa89f2ce1b1fac26e7cb5458851
https://doi.org/10.53730/ijhs.v6ns1.8698
https://doi.org/10.53730/ijhs.v6ns1.8698
Autor:
Deepa Ponnaiyan, C.m. Anitha, P.s.g. Prakash, Sangeetha Subramanian, Roshan Rughwani, Gayathri Kumar, Sowmya Nandipati
Publikováno v:
Exp Ther Med
Mucormycosis, which is a life threatening condition, is one of the side effects experienced by post-COVID-19 patients. Early identification and timely treatment are essential to stop the dissemination of the disease, since invasive mucormycosis has a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed5c5a773979da6058d9864a45e418e6
https://doi.org/10.3892/etm.2022.11746
https://doi.org/10.3892/etm.2022.11746
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Applied Health Economics and Health Policy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f852d33f80f13350757ba9d081eae241
https://doi.org/10.1007/s40258-021-00655-3
https://doi.org/10.1007/s40258-021-00655-3
Publikováno v:
World Academy of Sciences Journal. 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad11425ccc65b2afa91bd44719339852
https://doi.org/10.3892/wasj.2022.166
https://doi.org/10.3892/wasj.2022.166
Autor:
Bernd Schweikert, Gayathri Kumar, Susanne Hartz, Debby Nott, Sandeep Kiri, Christophe Sapin, Örjan Åkerborg, Chiara Malmberg
Publikováno v:
PharmacoEconomics Open
Background Interleukin-17A (IL-17A) antagonists are a recent innovation for treating psoriatic arthritis (PsA). There are currently no cost-effectiveness analyses (CEAs) comparing the IL-17A antagonists ixekizumab and secukinumab in PsA from a UK per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f03e40003468af7b35391ea5c18d5b8f
http://europepmc.org/articles/PMC7688884
http://europepmc.org/articles/PMC7688884